ALPS Group Inc Ordinary Share (NASDAQ:ALPS – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totaling 31,101 shares, a growth of 117.9% from the June 30th total of 14,273 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily volume of 450,688 shares, the short-interest ratio is currently 0.1 days.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of ALPS Group Inc Ordinary Share in a research report on Monday, July 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, ALPS Group Inc Ordinary Share has an average rating of “Sell”.
Get Our Latest Analysis on ALPS Group Inc Ordinary Share
ALPS Group Inc Ordinary Share Stock Performance
About ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See Also
- Five stocks we like better than ALPS Group Inc Ordinary Share
- UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
Receive News & Ratings for ALPS Group Inc Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Group Inc Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.
